📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis. (2023)

First Author: Topazian HM

Attributed to: MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2023.04.011

PubMed Identifier: 37080831

Publication URI: http://europepmc.org/abstract/MED/37080831

Type: Journal Article/Review

Volume: 41

Parent Publication: Vaccine

Issue: 20

ISSN: 0264-410X